1. Home
  2. KROS vs MMT Comparison

KROS vs MMT Comparison

Compare KROS & MMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

SELL

Current Price

$11.08

Market Cap

222.7M

Sector

Health Care

ML Signal

SELL

Logo MFS Multimarket Income Trust

MMT

MFS Multimarket Income Trust

BUY

Current Price

$16.27

Market Cap

234.0M

Sector

Finance

ML Signal

BUY

Company Overview

Basic Information
Metric
KROS
MMT
Founded
2015
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
222.7M
234.0M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
KROS
MMT
Price
$11.08
$16.27
Analyst Decision
Buy
Analyst Count
7
0
Target Price
★ $20.00
N/A
AVG Volume (30 Days)
202.3K
★ 227.1K
Earning Date
11-05-2026
01-01-0001
Dividend Yield
N/A
★ 8.58%
EPS Growth
★ 146.00
N/A
EPS
N/A
★ 0.30
Revenue
★ $243,864,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$55.40
Revenue Growth
N/A
N/A
52 Week Low
$8.98
$4.12
52 Week High
$22.55
$17.69

Technical Indicators

Market Signals
Indicator
KROS
MMT
Relative Strength Index (RSI) 54.21 84.24
Support Level $10.31 $4.28
Resistance Level $11.94 $17.69
Average True Range (ATR) 0.87 0.36
MACD 0.19 0.54
Stochastic Oscillator 64.52 89.07

Price Performance

Historical Comparison
KROS
MMT

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

About MMT MFS Multimarket Income Trust

Aberdeen Multi-Market Income Fund's investment objective is to seek high current income, but it may also consider capital appreciation.

Share on Social Networks: